Similar articles

• Portacaval shunt in four patients with homozygous hypercholesterolaemia.

  Stein EA, Pettifor J, Mieny C, Heimann KW, Spitz L, Bersohn I, Saaron I, Dinner M. Stein EA, et al. Lancet. 1975 Apr 12;1(7911):832-5. doi: 10.1016/s0140-6736(75)93005-6. Lancet. 1975. PMID: 48058
• Anti-platelet drugs and portacaval anastomosis for homozygous hypercholesterolaemia.

  Faergeman O, Gormsen J, Meinertz H. Faergeman O, et al. Lancet. 1976 Dec 25;2(8000):1416. doi: 10.1016/s0140-6736(76)91962-0. Lancet. 1976. PMID: 63884 No abstract available.
• Homozygous hypercholesteraemia and the portacaval shunt. The need for a concerted attack by surgeons and clinical researchers.

  Ahrens EH Jr. Ahrens EH Jr. Lancet. 1974 Aug 24;2(7878):449-51. doi: 10.1016/s0140-6736(74)91828-5. Lancet. 1974. PMID: 4136785 No abstract available.
• [Homozygote familial hypercholesterinemia. Pathophysiology and genetic control of cholesterol metabolism].

  Gaertner U. Gaertner U. Med Klin. 1978 Jun 9;73(23):849-54. Med Klin. 1978. PMID: 207958 Review. German. No abstract available.
• Portacaval shunt surgery and liver transplantation in the treatment of homozygous familial hypercholesterolemia.

  Bilheimer DW. Bilheimer DW. Prog Clin Biol Res. 1988;255:295-304. Prog Clin Biol Res. 1988. PMID: 3277200 Review. No abstract available.